Jill Marie Broadfoot is of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 4,280 shares of ACRX, which is worth approximately $4,836. The most recent transaction as insider was on Jun 24, 2024, when has been sold 2,174 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.28K
0% 3M change
103.23% 12M change
Total Value Held $4,836

Jill Marie Broadfoot Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Grant, award, or other acquisition
-
2,174 Added 33.68%
4,280 Common Stock
Oct 10 2023
BUY
Grant, award, or other acquisition
-
581 Added 21.62%
2,106 Common Stock
Jul 15 2022
BUY
Grant, award, or other acquisition
-
15,500 Added 33.7%
30,500 Common Stock
Nov 20 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

LIFE
aTYR PHARMA INC Healthcare
OTIC
OTONOMY, INC. Healthcare
JMB

Jill Marie Broadfoot

Hayward, CA

Track Institutional and Insider Activities on ACRX

Follow ACELRX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX